Elligo Health Research, an Austin, TX-based provider of a technology platform for clinical research, received a $40M venture loan facility from Horizon Technology Finance (NASDAQ: HRZN).
The company intends to use the loan proceeds for general growth and working capital purposes.
Led by John Potthoff, Ph.D., Founder and CEO, Elligo Health Research accelerates clinical trials through direct access to known, diverse patients from more than 115 hospitals and major health systems, 200 healthcare-based sites, and 100 research-based sites, leveraging EHR data and utilizing our proprietary IntElligo technology. Its PatientSelect® model engages networks to optimize the intersection of healthcare and research and bring more patients clinical research as a care option and its SiteSelect model and Research Partner Services enable sites to participate in trials, further advancing the development of new pharmaceutical, biotechnology, and medical device and diagnostic products.
Elligo is backed by investors including Morgan Stanley, Ally Bridge Group, Norwest Venture Partners, Piper Sandler, Noro-Moseley Partners and Hatteras Venture Partners.
Elligo Health Research, an Austin, TX-based provider of a technology platform for clinical research, received a $40M venture loan facility from Horizon Technology Finance (NASDAQ: HRZN). Best wishes to everyone in the group. This will be a huge accomplishment for them in the future.Shishir Gupta, The Founder & CEO of StartupLanes
About us: StartupLanes is an ecosystem for Startups and Investors. Collaborate or find a co-founder, it’s a platform for Entrepreneurs. We love startups! A place for Angel Investors and Venture Capitalists to find investing opportunities in startups. Validate your idea, Learn & Execute.
Startups looking for funding may apply through StartupLanes Funding Application.
Angel Investors Register Free to explore exciting startup investment opportunities.